Funding

Perceptive Discovery

United Kingdom · Biotech

Provides preclinical and translational solutions for oncology and radiopharmaceutical programs

Visit perceptive.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Strategic$15MCapVest Partners — Role not disclosed

Investors

CapVest PartnersStrategic

Coverage

Jan 8, 2026Perceptive Discovery · Strategic

Similar companies

Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourcesperceptive.com ↗